Shell Asset Management CO Voyager Therapeutics, Inc. Transaction History

Shell Asset Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$3.94 - $5.44 $339,107 - $468,209	-86,068 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$4.61 - $9.04 $193,836 - $380,104	42,047 Added 95.52%	86,068 $405,000
Q4 2020 Feb 16, 2021	BUY	$7.15 - $12.28 $236,343 - $405,915	33,055 Added 301.43%	44,021 $315,000
Q2 2020 Aug 10, 2020	BUY	$8.05 - $14.21 $88,276 - $155,826	10,966 New	10,966 $138,000

127

36.6M

48K

36.2K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $271M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.